...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith funding???

RVXOT...I thought that RVX and Zenith share labs and RVX would be reimbursed Zenith's share of the expenses. 

 

Koo

Share
New Message
Please login to post a reply